author-photo

Janet W. Baird

Glasgow Royal Infirmary

4

Papers

600

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

imatinib in primary CML, but does not eliminate the quiescent fraction Dasatinib (BMS-354825) targets an earlier progenitor population than

2013
Show All
- Source
- Cite
- Save
Citations (0)
Combined BCR-ABL inhibition with lentiviral-delivered shRNA and dasatinib augments induction of apoptosis in Philadelphia-positive cells.

2009 Experimental Hematology
Show All
- Source
- Cite
- Save
Citations (3)
Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

2006 Blood
Show All
- Source
- Cite
- Save
Citations (594)
Dasatinib (BMS-354825) Has Increased Activity Against Bcr-Abl Compared to Imatinib in Primary CML Cells In Vitro , but Does Not Eradicate Quiescent CML Stem Cells.

2005 Blood
Show All
- Source
- Cite
- Save
Citations (3)